Rozanolixizumab 560mg/4ml solution for infusion vials
- SNOMED code
44108411000001109- Active compound
- Rozanolixizumab
- Preferred name basis
- rINN - Recommended International Non-proprietary
- Prescribable
- ✅ Yes
- Dose form
- Discrete
- Dose size and units
- 4 ml, vial
- Ingredients
- Rozanolixizumab
— 140 mg
/ 1 ml
based on ingredient substance
- Form & Route
- solutioninfusion.subcutaneous
Solution for infusion, Subcutaneous - Controlled drug
- No Controlled Drug Status
Products
Rystiggo 560mg/4ml solution for injection vials (UCB Pharma Ltd)
Rystiggo 560mg/4ml solution for injection vials
- SNOMED code
44107311000001103- Supplier
- UCB Pharma Ltd
- Licensed as
- Medicines - MHRA/EMA
- EMA (European Medicines Agency) Monitoring
- ▼ Yes, black triangle marked
- Availability restrictions
- Restricted Availability
- Licensed route
- Subcutaneous
| Pack name & code | Status | GTIN, EAN barcodes | Price | Prescribing | Reimbursement | Pack |
|---|---|---|---|---|---|---|
Rystiggo 560mg/4ml solution for injection vials (UCB Pharma Ltd) 1 vial44107411000001105 ref. pack | 💯 Available Legal category: POM | 05413787222742 | NHS Indicative Price £17,883 | • Hospital |
| — |
Reference packs
Rozanolixizumab 560mg/4ml solution for infusion vials 1 vial
- SNOMED code
44107211000001106- Quantity and unit
- 1 vial
- Packs